PHILADELPHIA, PA — Context Therapeutics Inc. (Nasdaq: CNTX) announced it has granted stock options to purchase a total of 160,000 shares of common stock to two new employees as an inducement for joining the company.
The stock options were granted outside the 2021 Long-Term Performance Incentive Plan in line with Nasdaq Listing Rule 5635(c)(4).
The grants were made on the employees’ hire dates (May 5, 2025, and May 12, 2025) with exercise prices set at the closing prices of Context’s stock on those dates ($0.839 and $0.78 per share, respectively).
The options have a 10-year term and vest over four years: one-fourth vests on the first anniversary of the grant, and the rest in equal monthly installments over the next three years, subject to continued employment.
Support the local news that supports Chester County. MyChesCo delivers reliable, fact-based reporting and essential community resources—free for everyone. If you value that, click here to become a patron today.